Terms: = Lung cancer AND MEN1, ENSG00000133895, 4221 AND Prognosis
24 results:
1. Visual analysis of lung neuroendocrine tumors based on CiteSpace knowledge graph.
Guo M; Hu S; Xiao Y; Cao Z; Huang Z; Liu Y; An X; Zhang G; Zheng X
Front Endocrinol (Lausanne); 2023; 14():1214404. PubMed ID: 37745715
[TBL] [Abstract] [Full Text] [Related]
2. Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Himuro H; Nakahara Y; Igarashi Y; Kouro T; Higashijima N; Matsuo N; Murakami S; Wei F; Horaguchi S; Tsuji K; Mano Y; Saito H; Azuma K; Sasada T
Cancer Immunol Immunother; 2023 Aug; 72(8):2829-2840. PubMed ID: 37188764
[TBL] [Abstract] [Full Text] [Related]
3. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract] [Full Text] [Related]
4. lung Neuroendocrine Tumors: How Does Molecular Profiling Help?
Sun TY; Hendifar A; Padda SK
Curr Oncol Rep; 2022 Jul; 24(7):819-824. PubMed ID: 35305210
[TBL] [Abstract] [Full Text] [Related]
5. The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms.
Venizelos A; Elvebakken H; Perren A; Nikolaienko O; Deng W; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Krogh M; Sorbye H; Knappskog S
Endocr Relat Cancer; 2021 Nov; 29(1):1-14. PubMed ID: 34647903
[TBL] [Abstract] [Full Text] [Related]
6. Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.
Wang Y; Zhang H
J Int Med Res; 2021 Jan; 49(1):300060520961682. PubMed ID: 33435778
[TBL] [Abstract] [Full Text] [Related]
7. The Management of Neuroendocrine Tumors of the lung in men1: Results From the Dutch men1 Study Group.
van den Broek MFM; de Laat JM; van Leeuwaarde RS; van de Ven AC; de Herder WW; Dekkers OM; Drent ML; Kerstens MN; Bisschop PH; Havekes B; Hackeng WM; Brosens LAA; Vriens MR; Buikhuisen WA; Valk GD
J Clin Endocrinol Metab; 2021 Jan; 106(2):e1014-e1027. PubMed ID: 33135721
[TBL] [Abstract] [Full Text] [Related]
8. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol.
Bongiovanni A; Liverani C; Pusceddu S; Leo S; Di Meglio G; Tamberi S; Santini D; Gelsomino F; Pucci F; Berardi R; Lolli I; Bergamo F; Ricci S; Foca F; Severi S; Ibrahim T;
BMJ Open; 2020 Jul; 10(7):e034393. PubMed ID: 32690499
[TBL] [Abstract] [Full Text] [Related]
9. Integrative Genomic Characterization Identifies Molecular Subtypes of lung Carcinoids.
Laddha SV; da Silva EM; Robzyk K; Untch BR; Ke H; Rekhtman N; Poirier JT; Travis WD; Tang LH; Chan CS
Cancer Res; 2019 Sep; 79(17):4339-4347. PubMed ID: 31300474
[TBL] [Abstract] [Full Text] [Related]
10. Prostate cancer Incidence and Mortality in Relationship to Family History of Prostate cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract] [Full Text] [Related]
11. Histologically Proven Bronchial Neuroendocrine Tumors in men1: A GTE 51-Case Cohort Study.
Lecomte P; Binquet C; Le Bras M; Tabarin A; Cardot-Bauters C; Borson-Chazot F; Lombard-Bohas C; Baudin E; Delemer B; Klein M; Vergès B; Aparicio T; Cosson E; Beckers A; Caron P; Chabre O; Chanson P; Du Boullay H; Guilhem I; Niccoli P; Rohmer V; Guigay J; Vulpoi C; Scoazec JY; Goudet P
World J Surg; 2018 Jan; 42(1):143-152. PubMed ID: 28785839
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.
Ohmoto A; Rokutan H; Yachida S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098761
[TBL] [Abstract] [Full Text] [Related]
13. lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, men1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract] [Full Text] [Related]
14. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract] [Full Text] [Related]
15. Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1.
Bartsch DK; Albers MB; Lopez CL; Apitzsch JC; Walthers EM; Fink L; Fendrich V; Slater EP; Waldmann J; Anlauf M
Neuroendocrinology; 2016; 103(3-4):240-7. PubMed ID: 26113081
[TBL] [Abstract] [Full Text] [Related]
16. Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.
Du F; Yuan P; Wang JY; Ma F; Fan Y; Luo Y; Xu BH
Asian Pac J Cancer Prev; 2015; 16(3):903-7. PubMed ID: 25735380
[TBL] [Abstract] [Full Text] [Related]
17. The impact of thymoma histotype on prognosis in a worldwide database.
Weis CA; Yao X; Deng Y; Detterbeck FC; Marino M; Nicholson AG; Huang J; Ströbel P; Antonicelli A; Marx A;
J Thorac Oncol; 2015 Feb; 10(2):367-72. PubMed ID: 25616178
[TBL] [Abstract] [Full Text] [Related]
18. men1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.
Swarts DR; Scarpa A; Corbo V; Van Criekinge W; van Engeland M; Gatti G; Henfling ME; Papotti M; Perren A; Ramaekers FC; Speel EJ; Volante M
J Clin Endocrinol Metab; 2014 Feb; 99(2):E374-8. PubMed ID: 24276465
[TBL] [Abstract] [Full Text] [Related]
19. Two case reports of pilot percutaneous cryosurgery in familial multiple endocrine neoplasia type 1.
Li J; Zhang C; Chen J; Yao F; Zeng J; Huang L; Yang X; Liu W; Chen F; Xu K; Yang D; Niu L; Zuo J; Xu K; Liu D
Pancreas; 2013 Mar; 42(2):353-7. PubMed ID: 23407484
[TBL] [Abstract] [Full Text] [Related]
20. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery.
Borson-Chazot F; Garby L; Raverot G; Claustrat F; Raverot V; Sassolas G;
Ann Endocrinol (Paris); 2012 Dec; 73(6):497-502. PubMed ID: 23122576
[TBL] [Abstract] [Full Text] [Related]
[Next]
